Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Fluorouracil injection
Xeloda
Locations
12
United States
RWJBarnabas Health Clara Maas Medical Center
Belleville, New Jersey, United States
Trinitas Hospital and Comprehensive Cancer Center
Elizabeth, New Jersey, United States
RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton
Hamilton, New Jersey, United States
RWJBarnabas Health Jersey City Medical Center
Jersey City, New Jersey, United States
Cooperman Barnabas Medical Center
Livingston, New Jersey, United States
Jack and Sheryl Morris Cancer Center
New Brunswick, New Jersey, United States
Start Date
August 27, 2025
Primary Completion Date
July 7, 2027
Completion Date
July 7, 2029
Last Updated
November 13, 2025
NCT06608446
NCT07541924
NCT04389632
NCT07174336
NCT06966700
NCT04895709
Lead Sponsor
Rutgers, The State University of New Jersey
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions